MAOB and Parkinson disease: MAO-B inhibitors, such as Selegiline (l-Deprenyl), are useful in the treatment of Parkinson’s disease (PD) because they may preserve the depleted dopamine supply and elevate the levels of dopamine produced for exogenously administered levodopa [2].